dr. reddy's labs glp-1 receptor agonist Dr Enters the Race with Obeda: India's First Generic Semaglutide Launch Current Insights, Advantages and Challenges
Description
NM_012728.1: 5-GTATCTCTACGAGGACGAG-3
GIP as a therapeutic target in diabetes and obesity: insight from incretin Co-agonists
Green tea has been a popular drink and medicinal herb for centuries, dating back to the 14th century in China
In 2025 Spain co-hosted a side event at the 78th World Health Assembly, How the WHO Acceleration Plan to Stop Obesity is Unlocking Country Action where the Minister of Health announced that Spain will host the 2026 Global Stocktaking Summit on Obesity
Macrophage-mediated cholesterol handling in atherosclerosis
6% of patients in a matched cohort
